Metraipolis › archive › dc_0eceff72a496

Why 11β-HSD1 inhibitors show variable efficacy in Alzheimer's therapy: an APOE4-dependent HSD11B1 mechanism — Europe PMC PMID:41695490

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41695490
DOI
10.7150/thno.126244
License (as archived)
solo-consultazione
Archived
2026-11-06T15:50:17.918Z
SHA-256 of the archived text
315ec43d5fe57d48939a1969705dcb7f004cb79d99bd73501cb09339271790d2
Stable URL of this page
https://metraipolis.com/documento/dc_0eceff72a496

How to cite

Why 11β-HSD1 inhibitors show variable efficacy in Alzheimer's therapy: an APOE4-dependent HSD11B1 mechanism — Europe PMC PMID:41695490 — Europe PMC (en), https://europepmc.org/article/MED/41695490 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0eceff72a496 (Metraipolis archive dc_0eceff72a496, sha256 315ec43d5fe57d48939a1969705dcb7f004cb79d99bd73501cb09339271790d2)
BibTeX
@misc{dc0eceff72a496,
  title = {Why 11β-HSD1 inhibitors show variable efficacy in Alzheimer's therapy: an APOE4-dependent HSD11B1 mechanism — Europe PMC PMID:41695490},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41695490},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0eceff72a496; sha256 315ec43d5fe57d48939a1969705dcb7f004cb79d99bd73501cb09339271790d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41695490. Agents can read the archived copy with the MCP tool read_document.